YZYan Zhao

Yan Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yan Zhao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Dan Han

    Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

    3 shared publications
  • Fei Li

    Department of General Surgery, Second Affiliated Hospital, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, Shaanxi, China

    3 shared publications
  • Yan Zhou

    Department of Dermatology the First Affiliated Hospital of Xi'an Jiaotong University Xi'an China

    3 shared publications
  • Bei Liu

    Department of Dermatology and Medical Cosmetology, Tianhe Hospital Guangdong Second Provincial General Hospital Guangzhou Guangdong Province China

    2 shared publications
  • Bo Wang

    Translational Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Kuanhou Mou

    Department of Dermatology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications

Latest Publications

  • IL‐21 promoting angiogenesis contributes to the development of psoriasis

    by Dan Han, Fei Li, Yan Zhao, Bo Wang, Jingyuan Wang, Bei Liu, Kuanhou Mou, Liesu Meng, Yan Zheng, Shemin Lu, et al.

    Background: Elevated IL‐21 expression which can effectively induce Th17 cell differentiation has been implicated in the pathogenesis of psoriasis, but its role in angiogenesis remains poorly understood. Methods: PASI and PSI score assessment was applied to evaluate the severity of psoriatic lesions. The expression of IL‐21, IL‐21 receptor (IL‐21R), CD31, VEGFA, MMP‐9, and ICAM‐1 in skin was determined by immunohistochemistry or quantitative real‐time polymerase chain reaction. The serum level of IL‐21 was measured by enzyme‐linked immunosorbent assay (ELISA). Then, their correlation was analyzed statistically. Human umbilical vein endothelial cells (HUVECs) cocultured with conditional medium from normal human epidermal keratinocytes (NHEKs) were treated with IL‐21 and/or M5 cocktail (mixture of IL‐1α, IL‐17A, IL‐22, TNF‐α, and oncostatin M). The migration and tube formation of HUVECs were detected, and the levels of VEGFA, MMP‐9, and ICAM‐1 in NHEKs were measured by Western blotting or ELISA. Results: Increased IL‐21 and IL‐21R expression was observed in psoriatic sera or skin specimens, with IL‐21R mainly locating in keratinocytes and IL‐21 in immune cells. Pearson analysis showed significantly positive correlation between IL‐21/IL‐21R and erythema scores/microvessel density in psoriatic lesions. Moreover, the expression of proangiogenic genes, VEGFA, ICAM‐1, and MMP‐9 was upregulated in skins of psoriasis. Additionally, in M5 microenvironment, migration and tube formation could be magnified in HUVECs using IL‐21 pre‐treated NHEK medium. Mechanically, the co‐stimulation of IL‐21 and M5 to NEHKs increased the expression of ICAM‐1. Conclusion: IL‐21 could regulate keratinocytes to secrete ICAM‐1, thereby promoting angiogenesis in psoriasis.


  • Open Access

    The Association of Folic Acid, Iron Nutrition during Pregnancy and Congenital Heart Disease in Northwestern China: A Matched Case-Control Study

    by Ming-Xin Yan, Yan Zhao, Dou-Dou Zhao, Shao-Nong Dang, Ruo Zhang, Xin-Yu Duan, Pei-Xi Rong, Yu-Song Dang, Lei-Lei Pei, Peng-Fei Qu

    Background: The purpose of this study was to investigate the relationship between folic acid and iron nutrition during pregnancy and congenital heart disease (CHD) in the offspring. Methods: Conditional logistic regression models and nonlinear mixed-effects models were used to analyze the effects of folic acid and iron nutrition during pregnancy on CHD in offspring. Results: After adjusting for confounders, folic acid or iron supplementation during pregnancy reduced the risk for fetal CHD (OR = 0.60 (0.45, 0.82) or 0.36 (0.27, 0.48)). Similarly, dietary iron intake during pregnancy (≥29 mg/d) was associated with a reduced risk of fetal CHD (OR = 0.64 (0.46, 0.88)). Additionally, compared with women who only supplemented folic acid (OR = 0.59 (0.41, 0.84)) or iron (OR = 0.32 (0.16, 0.60)), women who supplemented both folic acid and iron had lower risk for newborns with CHD (OR = 0.22 (0.15, 0.34)). Similarly, compared with women who only supplemented folic acid (OR = 0.59 (0.41, 0.84)) or higher dietary iron intake (≥29 mg/d) (OR = 0.60 (0.33, 1.09)), women who supplemented both folic acid and higher dietary iron intake (≥29 mg/d) had lower risk for the newborn with CHD (OR = 0.41 (0.28, 0.62)). The combined effects were significant in the multiplication model (OR = 0.35 (0.26, 0.48) or 0.66 (0.50, 0.85)) but not in the additive model. Conclusions: Our study found that folic acid and iron nutrition during pregnancy were associated with a reduced risk of CHD in the offspring and confirmed a statistically significant multiplicative interaction between folic acid and iron nutrition on the reduced risk of CHD in offspring.


  • Open Access

    Multisystem Langerhans Cell Histiocytosis in Younger Infants First Presenting in Skin: A Case Series

    by Dan Han, Fei Li, Wahid H. Yahya, Rui Ge, Yan Zhao, Bei Liu, Yan Zhou, Zhuoyu Wen

    Objectives—To investigate the clinical characteristics, managements, outcome, and evaluate the risk factors of Multisystem (MS) Langerhans Cell Histiocytosis (LCH) with diverse skin lesions as the first sign in four young infants. Methods—Their clinical features, disease progression, therapy, and outcomes were reviewed and analyzed retrospectively. Results—The average onset age of skin lesions was about 2 months. Cases 1 and 2 had risk organs involved (RO+) and a lack of bone lesions, and progression could not be reversed by systemic chemotherapy. They both died eventually. Cases 3 and 4 (RO–) had bone involvement and were given systemic chemotherapy for a prolonged duration. Unluckily, Case 3 had a recurrence 2 years later, while Case 4’s recurrence happened nearly one year later, and diabetes insipidus one and a half years later. They both survived and are still in remission. Conclusion—MS-LCH infants with a low age of the first presentation in the skin are prone to dissemination, while RO+ is associated with high mortality. In addition, bone involvement may be a protective factor. Immunohistochemical examination of skin tissue facilitates correct early diagnosis, and adequate follow-up is necessary.


  • Open Access

    Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice

    by Fei Li, Dan Han, Bo Wang, Wentao Zhang, Yan Zhao, Jing Xu, Liesu Meng, Kuanhou Mou, Shemin Lu, Wenhua Zhu, et al.

    Itch is one of the major clinical manifestations of psoriasis, which is closely related with neurogenic inflammation and difficult to control. Colquhounia Root (CR) is a Chinese herb exhibiting broad bioactivities on anti-inflammation. This study was designed to explore the antipsoriatic and anti-itch potential of CR and its underlying mechanisms. Mice in a model of imiquimod-induced psoriasiform dermatitis were treated topically with CR for 7 days, and the severity of skin lesions and itch was significantly ameliorated. CR reduced the inflammatory cell infiltration, as well as mast cells in skins. Particularly, the expression of inflammatory cytokines and chemokine including Il17a, Il22, and Ccl20 and itch-related molecules such as SP, CGRP, and NGF in lesions were decreased in diseased mice upon application with CR. The normal human epidermal keratinocytes were stimulated with the M5 cytokine cocktail, the mixture of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α, and cell viability and mRNA expression levels of inflammatory factors and itch-related molecules were measured after being treated with CR. We found that CR inhibited both cell hyperproliferation and overexpression of inflammatory cytokines and itch-related molecules in vitro. Altogether, we conclude that CR relieves psoriatic lesions and itch via controlling immunological and neurogenic inflammation.